Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group
Oberg combines advanced weight loss medications with holistic treatments and health coaching to provide a custom, comprehensive weight loss program
DOI: 10.1016/j.diabet.2019.10.007
Who Might Benefit Zepbound may be the strongest option for Hashimoto's patients who: Have a BMI of 30 or greater, or 27 or greater with at least one weight-related condition Haven't achieved meaningful weight loss with other medications or lifestyle interventions Have significant insulin resistance or prediabetes alongside their Hashimoto's Carry improved inflammatory markers (hsCRP above 3.0 mg/L) Want the maximum weight loss potential currently available in a single medication Don't have a history of medullary thyroid cancer or MEN2 Zepbound is FDA-approved for chronic weight management, so Hashimoto's patients who meet the BMI criteria have a recognized pathway to treatment
313,314 In one study, OA was induced in rats by injecting MIA into the knee joint, mimicking the pathological changes of human OA
Nieto asegura que no pasa un da sin que alguien le pregunte en su consulta por este medicamento, pero a todos les repite que en la prdida de peso no hay atajos
